Home › Trial NCT00031928
Mafosfamide in Treating Patients With Progressive or Refractory Meningeal Tumors
- Trial IDNCT00031928
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorNational Cancer Institute (NCI)
- Enrollment3000
- Start date2002-01
- ConditionsBrain and Central Nervous System Tumors
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.